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Response by Benetos et al to Letter Regarding 
Article, “Hypertension Management in Older 
and Frail Older Patients”
In Response:
Kleipool et al commented on our recent article “Hypertension 
Management in Older and Frail Older Patients.”1 The authors of 
this comment point out that in addition to the functional and 
frailty status one should take into account the low diastolic blood 
pressure (DBP) levels often observed in very old individuals as a 
consequence of the development of aortic and another large artery 
stiffness.
No doubt this is a pertinent comment given the fact that DBP 
≤60 mm Hg has been shown to be associated with reduced sur-
vival, especially in the presence of high systolic blood pressure 
(SBP), suggesting that tailored antihypertensive treatment, not 
only based on SBP level, is needed.2 Indeed, such low DBP val-
ues are considered to induce problems with coronary perfusion, 
but strong evidence on the exact mechanisms of the potentially 
harmful effects of low DBP is lacking so far. It is actually possi-
ble that low DBP in older subjects is harmful mainly because it 
reflects high aortic stiffness. Our group has largely contributed to 
the knowledge of the mechanisms and the clinical consequences 
of the increase in SBP and the simultaneous decrease in DBP and 
the consequent elevation in pulse pressure in older adults.3,4
The aforementioned consequences of the arterial stiffness in 
the regulation of BP usually start being clinically significant af-
ter 60 years of age, whereas in patients with accelerated arterial 
aging due to the presence of specific conditions for example di-
abetes mellitus and end-stage renal failure, the simultaneous in-
crease in SBP and the decrease in DBP can occur even earlier in 
life. This process explains the strong increase in the prevalence 
of systolic hypertension after the age of 65 years. In middle-aged 
adults, hypertension is typically characterized by a concomitant 
increase of SBP, DBP, and consequent mean arterial pressure, 
mainly due to the increase in peripheral resistance.
We can, therefore, schematically distinguish 3 consecutive 
age-related arterial alterations influencing BP profiles: the first 
between 20 and 60 years of age, mainly characterized by the in-
crease of both SBP and DBP because of the increase in the pe-
ripheral resistance; the second between 60 and 80 years, mainly 
due to the stiffness of the aorta and the other central arteries and 
is characterized is by the increase in SBP and a decrease in DBP; 
and the third, often after the age of 80 years, characterized by 
variable evolution of BP levels mainly dependent on functional 
status, frailty, comorbidities, presence or not of heart failure, pol-
ypharmacy, malnutrition, dehydration, and many other geriatric 
conditions. All these conditions influence both mean SBP and 
DBP levels but also increase the variability of these parameters.
Our recent article focused on the necessary adaptations of the 
management of subjects aged 80 years and older under antihy-
pertensive treatment and high BP levels, especially those patients 
with a significant loss of function and autonomy.1 It is obvious, 
that since the aging process is a continuum, cardiovascular/BP 
status after the age of 80 years depends also on changes of both 
peripheral resistance, large artery stiffness earlier in life, and 
changes in heart function. At the same time, very old subjects 
with loss of function, cognitive disorders, and loss of autonomy—
although being the most important consumers of medications and 
other medical services—have systematically been excluded from 
the clinical trials.5 As recognized by the latest European Society 
of Cardiology/European Society of Hypertension guidelines for 
the management of arterial hypertension5 one of the major gaps 
in the evidence needing further studies, concerns the benefits of 
the antihypertensive treatment in very elderly (>80 years) and the 
influence of frailty. Therefore, at this stage, it is not possible to 
propose an antihypertensive strategy and target BP levels in this 
population based on strong evidence. In this respect, relying on 
the current evidence from the few randomized trials in relatively 
fit octogenarians and from observational studies in the frailest in-
dividuals of this age group, we proposed a practical algorithm 
taking into account the frailty/functional status.
In our article, we focused on the SBP measured with the 
standard methods at the supine or seated position because this 
is the variable that is used in most guidelines for older people. 
Although we admit the pertinence of the comment, we believe 
that at the current stage, the most important question is the one re-
lated to the very low SBP levels under antihypertensive treatment 
in frail older people. Adding DBP and pulse pressure criteria, or 
proposing different measurement methods (ie, self-measurement 
and orthostatic hypotension), might be less clear-cut in already 
complex daily practice of frail older patients.
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